42 results
DEF 14A
RNAZ
TransCode Therapeutics Inc
2 May 22
Definitive proxy
4:02pm
at Massachusetts General Hospital from June 2007 until September 2021. Dr. Medarova is a geneticist/cancer biologist by training. Dr. Medarova … 2020, Dr. Liu was employed in various scientific positions at Velico Medical, Inc. His postdoctoral training was at Harvard University
PRE 14A
RNAZ
TransCode Therapeutics Inc
31 Mar 23
Preliminary proxy
4:17pm
2007. Dr. Medarova is a geneticist/cancer biologist by training. Dr. Medarova is internationally recognized for her work on non-coding RNA for cancer … at Velico Medical, Inc. His post-doctoral training was at Harvard University in the Department of Molecular and Cellular Biology focusing on biochemistry
S-1
y3ap1kcng63h90zq6f
26 Feb 21
IPO registration
4:06pm
10-K
x03hl7 qcfd
31 Mar 22
Annual report
11:19am
424B4
imc5m0pzwr0e7l
9 Jul 21
Prospectus supplement with pricing info
5:22pm
10-Q
26fu sa3p8roj83
23 Aug 21
Quarterly report
4:53pm
DRS/A
brpcmh6nbrk5ekdvh1s
27 Jan 21
Draft registration statement (amended)
12:00am
424B4
vowdn hf9
19 Jan 24
Prospectus supplement with pricing info
9:57pm